• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1977 - 2016年肾细胞癌患者生存率的提高以及不同性别、种族和社会经济地位之间的差异

Survival Improvement in Patients with Renal Cell Carcinoma and Disparities between Different Sexes, Races, and Socioeconomic Status: 1977-2016.

作者信息

Ouyang Dijun, Sun Huanhuan, Chen Nan, Yan Yan, Ma Haiqing, Xia Jianchuan

机构信息

Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong, China.

Department of Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, Guangdong, China.

出版信息

J Oncol. 2022 Jul 30;2022:1587365. doi: 10.1155/2022/1587365. eCollection 2022.

DOI:10.1155/2022/1587365
PMID:35942409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9356869/
Abstract

OBJECTIVE

Rare research of renal cell carcinoma (RCC) has been made in a comprehensive and full description based on a long period of time as yet. This study was aimed at investigating the incidence and relative survival rates (RSRs) of RCC in the past forty years and to disclose the impact of sex, race, and socioeconomic status (SES) on RCC.

METHODS

The data as variables, including age, gender, race, and SES, were obtained from the Surveillance, Epidemiology, and End Results (SEER) database. SES was divided into three levels: low poverty, medium poverty, and high poverty. The medium- and high-poverty groups were integrated into one group in all analyses. The RSRs were calculated using period analysis methodology. Summary statistics including incidence and RSRs were analyzed by Kaplan-Meier and Cox proportional hazards models with GraphPad Prism 8.0.1 software and Stata 12.0 software.

RESULTS

A total of 77,513 patients diagnosed with RCC were enrolled in this study, showing an increased incidence and 10-year RSRs from 1977 to 2016. Patients older than 60 years had the highest incidence and the lowest RSRs. This research also showed significant disparities between different groups: incidence in males, blacks, and medium-high poverty groups was higher than that in females, whites, and low poverty groups, while RSRs were lower. For sex groups, the disparity of RSRs was obvious among patients who were 30-59 years old, but not among those younger than 29 years or older than 60 years. Based on SES, the survival gaps between different SES groups were getting wider over the past forty years.

CONCLUSION

This study showed how age, sex, race, and SES affected the incidence and RSRs of RCC, which may be beneficial for both better designed clinical trials and efficient prevention methods.

摘要

目的

迄今为止,尚未有基于较长时间段对肾细胞癌(RCC)进行全面且完整描述的研究。本研究旨在调查过去40年中RCC的发病率和相对生存率(RSRs),并揭示性别、种族和社会经济地位(SES)对RCC的影响。

方法

从监测、流行病学和最终结果(SEER)数据库中获取包括年龄、性别、种族和SES等变量的数据。SES分为三个水平:低贫困、中等贫困和高贫困。在所有分析中,将中等贫困和高贫困组合并为一组。使用期间分析方法计算RSRs。通过GraphPad Prism 8.0.1软件和Stata 12.0软件,采用Kaplan-Meier和Cox比例风险模型分析包括发病率和RSRs在内的汇总统计数据。

结果

本研究共纳入77513例诊断为RCC的患者,结果显示1977年至2016年发病率和10年RSRs均有所上升。60岁以上患者发病率最高,RSRs最低。本研究还显示不同组之间存在显著差异:男性、黑人以及中等-高贫困组的发病率高于女性、白人以及低贫困组,而RSRs则较低。对于性别组,30-59岁患者的RSRs差异明显,但在29岁以下或60岁以上患者中不明显。基于SES,在过去40年中,不同SES组之间的生存差距越来越大。

结论

本研究表明年龄、性别、种族和SES如何影响RCC的发病率和RSRs,这可能有助于设计更好的临床试验和有效的预防方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/9356869/b0ca852b6888/JO2022-1587365.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/9356869/12f959bdd5a6/JO2022-1587365.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/9356869/ec2738efabec/JO2022-1587365.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/9356869/a53cf926fd7b/JO2022-1587365.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/9356869/704a093a3ad3/JO2022-1587365.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/9356869/c815675cd046/JO2022-1587365.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/9356869/b0ca852b6888/JO2022-1587365.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/9356869/12f959bdd5a6/JO2022-1587365.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/9356869/ec2738efabec/JO2022-1587365.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/9356869/a53cf926fd7b/JO2022-1587365.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/9356869/704a093a3ad3/JO2022-1587365.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/9356869/c815675cd046/JO2022-1587365.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/9356869/b0ca852b6888/JO2022-1587365.006.jpg

相似文献

1
Survival Improvement in Patients with Renal Cell Carcinoma and Disparities between Different Sexes, Races, and Socioeconomic Status: 1977-2016.1977 - 2016年肾细胞癌患者生存率的提高以及不同性别、种族和社会经济地位之间的差异
J Oncol. 2022 Jul 30;2022:1587365. doi: 10.1155/2022/1587365. eCollection 2022.
2
The fluctuating incidence, improved survival of patients with breast cancer, and disparities by age, race, and socioeconomic status by decade, 1981-2010.1981年至2010年期间乳腺癌发病率的波动、患者生存率的提高以及按年龄、种族和社会经济地位划分的十年间差异。
Cancer Manag Res. 2018 Oct 30;10:4899-4914. doi: 10.2147/CMAR.S173099. eCollection 2018.
3
Trends in Incidence and Survival of Patients with Pancreatic Neuroendocrine Neoplasm, 1987-2016.1987 - 2016年胰腺神经内分泌肿瘤患者的发病率及生存率趋势
J Oncol. 2021 Dec 22;2021:4302675. doi: 10.1155/2021/4302675. eCollection 2021.
4
Trend in relative survival in squamous cervical cancer by decade from 1983 to 2012: a period analysis.1983年至2012年按十年划分的宫颈鳞癌相对生存率趋势:一项时期分析。
Cancer Manag Res. 2018 Sep 3;10:3177-3191. doi: 10.2147/CMAR.S167442. eCollection 2018.
5
Trends in incidence and survival in patients with gastrointestinal neuroendocrine tumors: A SEER database analysis, 1977-2016.胃肠道神经内分泌肿瘤患者的发病率和生存率趋势:一项1977 - 2016年的监测、流行病学和最终结果(SEER)数据库分析
Front Oncol. 2023 Jan 26;13:1079575. doi: 10.3389/fonc.2023.1079575. eCollection 2023.
6
Inequality in Female Breast Cancer Relative Survival Rates between White and Black Women in the United States.美国白人和黑人女性乳腺癌相对生存率的不平等。
J Racial Ethn Health Disparities. 2024 Jul 3. doi: 10.1007/s40615-024-02079-w.
7
Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.肝细胞癌发病率、分期和生存率的差异:一项大型基于人群的研究。
Cancer Epidemiol Biomarkers Prev. 2021 Jun;30(6):1193-1199. doi: 10.1158/1055-9965.EPI-20-1088. Epub 2021 Mar 18.
8
Increased survival rates in gastric cancer, with a narrowing gender gap and widening socioeconomic status gap: A period analysis from 1984 to 2013.胃癌生存率提高,性别差距缩小,社会经济地位差距扩大:1984 年至 2013 年的时间分析。
J Gastroenterol Hepatol. 2018 Apr;33(4):837-846. doi: 10.1111/jgh.14024. Epub 2018 Feb 6.
9
Analysis and Prediction of the Survival Trends of Patients with Clear-Cell Renal Cell Carcinoma: A Model-Based Period Analysis, 2001-2015.基于模型的时期分析 2001-2015 年透明细胞肾细胞癌患者生存趋势分析及预测。
Cancer Control. 2022 Jan-Dec;29:10732748221121226. doi: 10.1177/10732748221121226.
10
Long-Term Survival Rates of Patients with Stage III-IV Hodgkin Lymphoma According to Age, Sex, Race, and Socioeconomic Status, 1984-2013.1984-2013 年,根据年龄、性别、种族和社会经济地位,III-IV 期霍奇金淋巴瘤患者的长期生存率。
Oncologist. 2018 Nov;23(11):1328-1336. doi: 10.1634/theoncologist.2017-0541. Epub 2018 May 8.

引用本文的文献

1
The Impact of Nursing Interventions on the Treatment Outcomes of Renal Cell Carcinoma with Postoperative Interleukin-2 and Recombinant Human Interferon.护理干预对肾细胞癌术后使用白细胞介素-2和重组人干扰素治疗效果的影响
J Multidiscip Healthc. 2024 Feb 17;17:735-741. doi: 10.2147/JMDH.S447537. eCollection 2024.

本文引用的文献

1
Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma.超越传统免疫检查点抑制——肾细胞癌的新型免疫疗法
Nat Rev Clin Oncol. 2021 Apr;18(4):199-214. doi: 10.1038/s41571-020-00455-z. Epub 2021 Jan 12.
2
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
3
The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.肾细胞癌的癌症基因组图谱:发现与临床意义。
Nat Rev Urol. 2019 Sep;16(9):539-552. doi: 10.1038/s41585-019-0211-5. Epub 2019 Jul 5.
4
Epidemiology of Renal Cell Carcinoma.肾细胞癌的流行病学。
Eur Urol. 2019 Jan;75(1):74-84. doi: 10.1016/j.eururo.2018.08.036. Epub 2018 Sep 19.
5
Health Effects of Overweight and Obesity in 195 Countries over 25 Years.25年间195个国家超重和肥胖对健康的影响
N Engl J Med. 2017 Jul 6;377(1):13-27. doi: 10.1056/NEJMoa1614362. Epub 2017 Jun 12.
6
Renal cell carcinoma.肾细胞癌。
Nat Rev Dis Primers. 2017 Mar 9;3:17009. doi: 10.1038/nrdp.2017.9.
7
Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling.雄激素受体 (AR) 信号通过调节 AKT→NF-κB→CXCL5 信号促进内皮细胞增殖和募集,从而促进 RCC 的进展。
Sci Rep. 2016 Nov 16;6:37085. doi: 10.1038/srep37085.
8
Renal cell carcinoma: links and risks.肾细胞癌:关联与风险。
Int J Nephrol Renovasc Dis. 2016 Mar 7;9:45-52. doi: 10.2147/IJNRD.S75916. eCollection 2016.
9
Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors.年轻且肿瘤较小的肾细胞癌患者总体生存中的种族差异。
Cancer Med. 2016 Feb;5(2):200-8. doi: 10.1002/cam4.578. Epub 2015 Dec 29.
10
Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial.基于前列腺、肺、结肠直肠和卵巢癌筛查试验以及国家肺癌筛查试验参与者的肾细胞癌风险估计。
Urol Oncol. 2016 Apr;34(4):167.e9-16. doi: 10.1016/j.urolonc.2015.10.011. Epub 2015 Nov 18.